| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
* Department of Microbiology, Immunology and Molecular Genetics,
Medical Scientist Training Program,
Molecular Biology Institute,
Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
B kinase (TANK)-binding kinase 1 (TBK1). Interestingly, receptor-interacting protein 2, a component of the recently discovered nucleotide-binding oligomerization domain-dependent intracellular detection pathway, was not involved. Taken together, our data describe a novel signal transduction pathway involving TBK1 that is used by LM to activate type I IFNs. Additionally, we provide evidence that both the LM- and TLR-dependent pathways converge at TBK1 to activate type I IFNs, highlighting the central role of this molecule in modulating type I IFNs in host defense and disease. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Induction of type I IFN gene expression in response to both viral and bacterial infections is modulated by IFN regulatory factor (IRF) family members (8, 9, 10). IRF3 has been shown to be the earliest player, and normally exists in an unactivated state in the cytoplasm of most cell types. Upon detection of a viral or bacterial infection, IRF3 becomes activated by phosphorylation and subsequently participates in the transactivation of IFN
. Once produced, secreted IFN acts in an autocrine/paracrine manner by binding to its receptor. This in turn results in the activation of transcriptional complexes involving STAT1, STAT2, IRF9, and IRF7, which up-regulate a large set of IFN inducible genes, including multiple IFN-
subtypes (11, 12).
Although the precise mechanisms of viral and bacterial detection and triggering of the IRF3 pathway remain unclear, several advances have recently been made. TNFR-associated NF-B kinase (TANK)-binding kinase 1 (TBK1) and I-B kinase 
(IKK) have been shown to be the critical kinases required for phosphorylation of IRF3 in response to viral infection (13, 14, 15, 16). In addition, studies in several laboratories including our own have linked activation of type I IFNs to TLRs, a family of receptors that recognize conserved molecular structures from pathogens (10, 17, 18). Specifically, TLR3, the receptor for double-stranded RNA, and TLR4, the receptor for LPS, could activate the type I IFN pathway by inducing the phosphorylation and nuclear translocation of IRF3 in a TBK1-dependent manner (16). Stimulation of TLR3 or TLR4 also inhibited replication of murine gammaherpesvirus 68, suggesting a potential role for these TLRs in antiviral host defense (19). In addition, TLR9, which recognizes hypomethylated DNA found in both bacteria and viruses, has also been shown to induce type I IFN in certain dendritic cell types (20). Although TLR3 and TLR4 require the adaptor molecule Toll-IL-1-receptor domain-containing adaptor-inducing IFN- to up-regulate type I IFN (21), TLR9 is dependent on MyD88 (20).
As type I IFNs are induced by LM leading to a disrupted innate immune response, we sought to investigate the mechanism by which LM up-regulates this pathway. Our studies indicate that type I IFN is triggered by LM independent of TLR4 and TLR2 signaling. Furthermore, induction of type I IFNs by LM was delayed in comparison to the Gram-negative bacterium Escherichia coli, which requires TLR4. Finally, we found that LM must enter the macrophage cytoplasm and activate IRF3 through a mechanism involving TBK1. Collectively, these findings suggest that LM activation of type I IFNs occurs through a TLR4-independent and novel cytoplasmic receptor system, which uses TBK1 to activate the type I IFN system.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
C57BL/6 mice age 6–12 wk were obtained from The Jackson Laboratory. TLR2–/–, TLR4–/– and wild-type control mice, all on a C57BL/6 genetic background, were a kind gift from Dr. S. Akira (Osaka University, Osaka, Japan). TBK1+/+TNFR1+/+, TBK1+/+TNFR1–/–, and TBK1–/–TNFR1–/– mice have been previously described (16). All mice, along with the receptor interacting protein (RIP) 2-deficient mice generated by our laboratory, were maintained and bred under specific pathogen-free conditions in the University of California (Los Angeles, CA), Department of Laboratory Animal Medicine mouse facility and experiments were conducted within the parameters of our approved protocol.
Bacteria
Bacteria used in this study were the following: LM strain 10403S; E. coli strain K-12 (American Type Culture Collection catalog no. 10798); and Staphylococcus aureus strain 8325 (origin NCTC). Additional LM strains used were the following: the 
hly deletion mutant EJL1, and actA deletion mutant EJL2. LM was grown in brain-heart infusion broth with 200 µg/ml streptomycin (BD Microbiology Systems). E. coli and S. aureus were both grown in lennox L broth base (Invitrogen Life Technologies). Bacteria were grown to mid-logarithmic phase, pelleted, washed, and resuspended in PBS three times, and stored as glycerol stocks at –80°C in small aliquots until use. The concentration of bacteria was quantified by plating serial dilutions on appropriate agar plates and counting colonies after growth at 37°C for 24–36 h.
Cell culture
Murine bone marrow-derived macrophages (BMDMs) were obtained by differentiating bone marrow. Briefly, bone marrow cells were flushed out of femurs and tibias, RBC were depleted and the remaining cells were maintained in macrophage differentiating medium (1x DMEM (Mediatech), 10% FBS, penicillin (100 U/ml), streptomycin (100 µg/ml), and 30% L929 conditioned medium) for 7 days. Approximately 96–99% of the differentiated macrophage cells were CD11b+ and negative for various contaminating markers. TBK1–/– immortalized fibroblast cells were a kind gift from W. C. Yeh (University of Toronto, Ontario, Canada) and were maintained in 1x DMEM, 10% FBS, penicillin (100 U/ml), and streptomycin (100 µg/ml). The chemical inhibitor concanamycin A (CNA) was obtained from Sigma-Aldrich. Cells were pretreated with the inhibitor at the indicated concentration for 30 min and for the entire length of the infection.
Immunoblotting
Cells were fractionated and their nuclear and cytoplasmic portions were size fractionated. Detailed protocols are available on our laboratory website (
www.mimg.ucla.edu/faculty/cheng/fac_cheng.html
). The anti-IRF3 Ab was obtained from Zymed Laboratories, whereas both the anti-upstream stimulating factor (USF)-2 and anti-STAT1 Abs were obtained from Santa Cruz Biotechnologies. Finally the phospho-STAT1 Ab was purchased from Cell Signaling Technologies.
Quantitative real-time PCR (Q-PCR)
RNA was isolated using the TRIzol Reagent (Invitrogen Life Technologies). RNA was quantitated and 1 µg of RNA was used to make cDNA templates using iScript per manufacturer’s suggested protocol (Bio-Rad). Q-PCR analyses were done using the iCycler thermocycler (Bio-Rad) as described (19). The following primers were used to amplify a specific 100–120 bp fragment of the following genes: IFN- 5'-AGCTCCAAGAAAGGACGAACAT, IFN- 3'-GCCCTGTAGGTGAGGTTGATCT; TNF- 5'-GGTGCCTATGTCTCAGCCTCTT, TNF- 3'-CGATCACCCCGAAGTTCAGTA; L32 5'-AAGCGAAACTGGCG GAAAC, L32 3'-TAACCGATGTTGGGCATCAG. All sample values have been normalized to their average L32 values and are presented as relative expression units.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
A number of studies have clearly demonstrated that type I IFNs can be induced by bacteria such as LM (9, 22, 23). To determine the relative abilities of different bacterial pathogens to induce the type I IFN system, we examined the response of primary murine BMDMs to infection by three types of bacteria: E. coli (Gram-negative, extracellular), LM (Gram-positive, intracellular) and S. aureus (Gram-positive, extracellular). Fig. 1A shows that E. coli, a Gram-negative bacterium, is able to quickly induce nuclear translocation of IRF3, the transcription factor associated with initiation of the type I IFN response. We also found that the Gram-positive bacterium LM, but not S. aureus, induced a strong response. Of interest was the fact that LM activation of type I IFN was delayed and prolonged compared with E. coli. Translocation of p65, a component of the NF-B pathway, was similar in response to all bacteria tested, and USF2 is shown as a loading control. Immunoblotting for phosphorylated STAT1 (Fig. 1B) confirmed that LM induced a potent but delayed activation of the type I IFN pathway relative to E. coli. The dependency of STAT1 activation on type I IFN during an LM infection has been previously demonstrated by Stockinger et al. (23). Gene expression analysis using Q-PCR revealed that on a per bacterium basis, LM was the strongest inducer of IFN- mRNA (Fig. 1C). However, TNF- mRNA was more potently induced by E. coli relative to LM (Fig. 1C).
|
Fig. 1 demonstrates that LM induction of type I IFN follows different kinetics and reaches higher levels than those observed in E. coli infected cells. This pattern suggested to us that E. coli, a Gram-negative bacterium, might use distinct mechanisms to induce type I IFN expression from the Gram-positive bacterium LM. In an effort to identify the mechanism by which LM can activate the type I IFN system, we first analyzed the contribution of TLR4, which is found on the cell surface of BMDMs and can induce the expression of type I IFN in response to certain bacteria or bacterial products (24). We found that although IFN- expression and subsequent STAT1 phosphorylation by BMDMs in response to E. coli was dependent upon TLR4 (Figs. 2, A and B), induction of this pathway by LM remained intact in TLR4–/– BMDMs (Fig. 2, C and D). These findings reveal that although E. coli requires TLR4 to activate the type I IFN pathway, LM uses a unique, TLR4-independent mechanism.
|
mRNA and STAT1 phosphorylation, in response to LM (Fig. 2, C and D). This is consistent with in vitro studies indicating that TLR2 signaling does not induce expression of IFN- in BMDMs (10). Additionally, BMDMs deficient in IL-1R-associated kinase 4 or TNFR-associated factor 6, both of which are components of the MyD88 signaling pathway (24), had no defects in type I IFN production in response to LM (data not shown). Induction of type I IFNs by LM requires cytosolic entry
Although a facultative intracellular bacterium, LM must initially come into contact with cell surface and phagosomal surveillance molecules, such as TLR2 and TLR4, on its way into the cytoplasm. However, it is clear from our findings that these particular receptors are not required for activation of type I IFN in response to LM. These observations caused us to question whether the cellular detection of LM leading to type I IFN production was dependent upon an extracellular or cytosolic receptor(s).
Evidence for a cytoplasmic receptor system has come from two independent studies showing that LM requires the hly gene to activate the type I IFN pathway in macrophages (22, 23). The hly gene encodes the protein listeriolysin O (LLO) that enables escape from the phagosome and entry into the cytoplasm. As expected, we also found that hly-deficient LM mutants were unable to activate the type I IFN response (Fig. 3, A and B). Furthermore, a LM mutant deficient in actA, which can reach the cytoplasm but cannot polymerize actin, was able to induce type I IFNs to the same degree as wild-type LM. This demonstrates that actin polymerization by LM is not required for type I IFN induction. To further corroborate these findings, we examined whether LM can induce the type I IFN pathway in BMDMs that have been treated with the chemical inhibitor CNA, which prevents phagolysosomal acidification (25). Under these conditions, LM entry into the cytosol is disrupted (26), which we found to inhibit LM from inducing the type I IFN pathway (Fig. 3, C and D). TNF- mRNA was still induced normally in the presence of CNA (Fig. 3D). These findings prompted us to shift our focus toward known intracellular pathways in the hopes of identifying a link of cytosolic origin between LM and type I IFN expression.
|
The nucleotide-binding oligomerization domain (Nod) family of proteins has been shown to function as pattern recognition receptors that can detect and respond to conserved pathogenic motifs encountered within the cytoplasm (27). Following target binding, Nod1 and Nod2 signal through RIP2 (28). The importance of RIP2 in conferring immunity against LM is exemplified by a severe defect in LM clearance in mice deficient in the RIP2 gene (29). However, the involvement of the Nod1/2-RIP2 signaling pathway in type I IFN activation has not been studied. To decipher whether RIP2 is required for type I IFN production following infection with LM, we infected BMDMs deficient in RIP2. However, we found no impairment in IRF3 activation (Fig. 4A), type I IFN production (Fig. 4C) or STAT1 activation (Fig. 4B) in RIP2-deficient cells.
|
production in response to TLR signaling, viral infection and infection by LM (8, 9, 10, 17). Furthermore, as indicated in Fig. 1A, LM infection induces nuclear translocation of IRF3. As TBK1 has recently been implicated in IRF3 activation in response to viral infections and TLR signaling (15), we tested whether TBK1 is also involved in IRF3 activation leading to type I IFN production following infection with LM. We found that activation of IRF3 (Fig. 5A), induction of type I IFN expression (Fig. 5C) and activation of STAT1 (Fig. 5B) by LM were all dependent upon TBK1 following LM infection in mouse embryonic fibroblasts (MEF) derived from TBK1-deficient mice and wild-type littermates. The specificity of the TBK1 defect in IRF3 activation and type I IFN production is demonstrated by the fact that nuclear translocation of the NF-B subunit p65 is not dependent upon TBK1 (Fig. 5A). Furthermore, we found that LM was able to replicate intracellularly in both wild-type and TBK1-deficient MEF (data not shown).
|
mRNA up-regulation and STAT1 phosphorylation compared with both wild-type and TBK1+/+TNFR1–/– controls (Fig. 5, D and E). These data indicate that TBK1 is required for proper LM induction of type I IFNs in multiple cell types. |
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
, which is expressed in BMDMs but not MEFs (16), can likely play a partially redundant role in activating the type I IFN system following infection by LM. This might explain why we still observe slight induction of IFN- and activation of STAT1 in TNFR1–/–TBK1–/– BMDMs. Furthermore, the kinetics of type I IFN production following infection with either LM or viruses are delayed in comparison to type I IFNs produced in response to Gram-negative bacteria, such as E. coli (10, 31).
Our findings also clearly demonstrate that although E. coli uses a TLR4-dependent mechanism to induce type I IFN expression within 1 h of macrophage challenge, LM does not require TLR4 and reaches maximal induction by 4 h. These data are consistent with recent observations that macrophages deficient in Toll-IL-1-receptor domain-containing adaptor-inducing IFN-, the adaptor that allows TLR3 and TLR4 activation of type I IFNs, can still produce type I IFNs in response to LM (5). Collectively, these observations indicate that host production of type I IFNs in response to bacterial pathogens can occur via at least two independent receptor systems.
There are thus far two innate immune signaling pathways that appear to play nonredundant roles in combating infection by LM. These pathways include RIP2 (29) and MyD88 (32, 33). RIP2 is involved in the activation of NF-B in macrophages and IFN-
production in both Th1 and NK cells (29). As the Th1 response is critical in combating LM, it is not surprising that mice deficient in RIP2 are extremely sensitive to infection by this pathogen. Mice deficient in MyD88 have been shown to have severe defects in the production of proinflammatory cytokines, such as TNF-, in response to a LM challenge in vivo (32, 33). As a result, these mice are also very susceptible to infection by LM. A recent study by Way et al. (34) has shown that MyD88 is not required for the adaptive immune response against LM. These findings provide evidence that MyD88 is important in the early inflammatory response (32, 33). As type I IFNs have recently been shown to play an opposite role from MyD88 and RIP2 and inhibit the immune response to LM, it is not surprising that these two pathways are not involved in the induction of type I IFNs (9).
Additional studies are still required to further clarify the molecular process by which LM is able to activate IRF3 once inside the cytoplasm. Although this mechanism requires LLO, a recent study has found that purified LLO alone is not sufficient to induce type I IFNs in macrophages. These observations support the hypothesis that type I IFN activation is driven by a cytosolic surveillance system that can detect the presence of certain bacteria and is not simply induced by LLO alone (35). In addition to identifying host proteins that participate in the recognition of LM and subsequent activation of signaling cascades leading to TBK1, it will be of importance to identify which LM component is serving as a ligand for the unknown host cytosolic receptor. Because LM induction of the type I IFN pathway plays a negative role in host defense against this opportunistic pathogen, a clear understanding of the mechanism by which LM can induce these cytokines is imperative. Such information should enable the design of strategic molecular interventions to combat the deleterious effects on the mammalian host following infection by bacterial pathogens such as LM.
|
Acknowledgments |
|---|
|
Footnotes |
|---|
1 This work was supported in part by the National Institutes of Health research Grants R01 AI056154, R01 CA87924, and R01 AI052359. R.M.O. is supported by the U.S. Public Health Service National Research Service Award GM 07185. S.A.V. and S.K.S. are supported by the University of California Los Angeles Medical Scientist Training Program training Grant GM 08042. A.P. is supported by the Howard Hughes Medical Institute predoctoral fellowship (No. 59003787). 
2 R.M.O. and S.A.V. contributed equally to this work.
3 Address correspondence and reprint requests to Dr. Genhong Cheng, Department of Microbiology, Immunology and Molecular Genetics, 8–240 Factor Building, University of California, 10833 Le Conte Avenue, Los Angeles, CA 90095. E-mail address: genhongc{at}microbio.ucla.edu
4 Abbreviations used in this paper: LM, Listeria monocytogenes; BMDM, bone marrow-derived macrophage; CNA, concanamycin A; IKK, I-B kinase ; IRF, IFN regulatory factor; Q-PCR, quantitative real-time PCR; Nod2, nucleotide-binding oligomerization domain 2; LLO, listeriolysin O; RIP, receptor interacting protein; TANK, TNFR-associated NF-B kinase; TBK1, TANK-binding kinase 1; MEF, mouse embryonic fibroblast; USF, upstream stimulating factor.
Received for publication August 2, 2004. Accepted for publication November 15, 2004.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
and as immune regulators: a new look. Immunity 14:661.[Medline]
, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169:4279. system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14:111.[Medline]
and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491.[Medline]
B activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 18:6694.[Medline]
-induced STAT1/-dependent gene expression in macrophages. Nat. Immunol. 3:392.[Medline]
in Toll-like receptor-stimulated dendritic cell activation. Int. Immunol. 14:1225.B-dependent gene transcription. EMBO J. 19:4976.[Medline]
/ gene induction. Immunity 13:539.[Medline]
This article has been cited by other articles:
|
|
 |
|
  L. E. Cole, A. Santiago, E. Barry, T. J. Kang, K. A. Shirey, Z. J. Roberts, K. L. Elkins, A. S. Cross, and S. N. Vogel Macrophage Proinflammatory Response to Francisella tularensis Live Vaccine Strain Requires Coordination of Multiple Signaling Pathways J. Immunol., May 15, 2008; 180(10): 6885 - 6891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wang, L. Chen, E. Ahmed, L. Ma, D. Yin, P. Zhou, J. Shen, H. Xu, C.-R. Wang, M.-L. Alegre, et al. Prevention of Allograft Tolerance by Bacterial Infection with Listeria monocytogenes J. Immunol., May 1, 2008; 180(9): 5991 - 5999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Reimer, M. Schweizer, and T. W. Jungi Type I IFN Induction in Response to Listeria monocytogenes in Human Macrophages: Evidence for a Differential Activation of IFN Regulatory Factor 3 (IRF3) J. Immunol., July 15, 2007; 179(2): 1166 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nomura, I. Kawamura, C. Kohda, H. Baba, Y. Ito, T. Kimoto, I. Watanabe, and M. Mitsuyama Irreversible loss of membrane-binding activity of Listeria-derived cytolysins in non-acidic conditions: a distinct difference from allied cytolysins produced by other Gram-positive bacteria Microbiology, July 1, 2007; 153(7): 2250 - 2258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tamassia, V. Le Moigne, F. Calzetti, M. Donini, S. Gasperini, T. Ear, A. Cloutier, F. O. Martinez, M. Fabbri, M. Locati, et al. The MYD88-Independent Pathway Is Not Mobilized in Human Neutrophils Stimulated via TLR4 J. Immunol., June 1, 2007; 178(11): 7344 - 7356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Stanley, J. E. Johndrow, P. Manzanillo, and J. S. Cox The Type I IFN Response to Infection with Mycobacterium tuberculosis Requires ESX-1-Mediated Secretion and Contributes to Pathogenesis J. Immunol., March 1, 2007; 178(5): 3143 - 3152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Opitz, M. Vinzing, V. van Laak, B. Schmeck, G. Heine, S. Gunther, R. Preissner, H. Slevogt, P. D. N'Guessan, J. Eitel, et al. Legionella pneumophila Induces IFNbeta in Lung Epithelial Cells via IPS-1 and IRF3, Which Also Control Bacterial Replication J. Biol. Chem., November 24, 2006; 281(47): 36173 - 36179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Pietras, S. K. Saha, and Genhong Cheng The interferon response to bacterial and viral infections Innate Immunity, August 1, 2006; 12(4): 246 - 250. [Abstract] [PDF]
|
|
|
|
|
|
B. Opitz, A. Puschel, W. Beermann, A. C. Hocke, S. Forster, B. Schmeck, V. van Laak, T. Chakraborty, N. Suttorp, and S. Hippenstiel Listeria monocytogenes Activated p38 MAPK and Induced IL-8 Secretion in a Nucleotide-Binding Oligomerization Domain 1-Dependent Manner in Endothelial Cells J. Immunol., January 1, 2006; 176(1): 484 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. M. Nagarajan, D. M. Ojcius, L. Stahl, R. G. Rank, and T. Darville Chlamydia trachomatis Induces Expression of IFN-{gamma}-Inducible Protein 10 and IFN-{beta} Independent of TLR2 and TLR4, but Largely Dependent on MyD88 J. Immunol., July 1, 2005; 175(1): 450 - 460. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
